Incidence of Adverse Cardiac Events 5 Years after Polymer‐free Sirolimus Eluting Stent Implantation: Results from the Prospective Bad Berka Yukon Choice™ Registry

Marc-Alexander Ohlow,Hubertus von Korn,Oliver Gunkel,Ahmed Farah,Joerg T. Fuhrmann,Bernward Lauer

Catheterization and cardiovascular interventions（2013）

引用 6|浏览5

暂无评分

摘要

Drug‐eluting stents (DES) constitute a major achievement in preventing re‐stenosis, concerns remain regarding the increased inflammatory responses associated with the polymers used. This analysis focuses on outcomes in patients receiving the polymer‐free sirolimus‐eluting stent system YUKON‐Choice (Yukon‐DES, Translumina, Germany).

查看译文

关键词

sirolimus eluting stent,Yukon choice,5-year results,outcome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要